Cargando…

Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival

CD200R1 expressed on the surface of myeloid and lymphoid cells delivers immune inhibitory signals to modulate inflammation when engaged with its ligand CD200. Signalling through CD200/CD200R1 has been implicated in a number of immune-related diseases including allergy, infection, cancer and transpla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prodeus, Aaron, Cydzik, Marzena, Abdul-Wahid, Aws, Huang, Eric, Khatri, Ismat, Gorczynski, Reginald, Gariépy, Jean
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4221601/ https://www.ncbi.nlm.nih.gov/pubmed/25158092 http://dx.doi.org/10.1038/mtna.2014.41

Ejemplares similares

A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo
por: Prodeus, Aaron, et al.
Publicado: (2018)

Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
por: Prodeus, Aaron, et al.
Publicado: (2015)

Cure of metastatic growth of EMT6 tumor cells in mice following manipulation of CD200:CD200R signaling
por: Gorczynski, Reginald M., et al.
Publicado: (2013)

Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model
por: Curry, Anna, et al.
Publicado: (2017)

Characterization of CD200 Ectodomain Shedding
por: Wong, Karrie K., et al.
Publicado: (2016)

Can CD200R1 Agonists Slow the Progression of Osteoarthritis Secondary to Injury?
por: Vachhani, Kathak, et al.
Publicado: (2022)

Comparison of Immunity in Mice Cured of Primary/Metastatic Growth of EMT6 or 4THM Breast Cancer by Chemotherapy or Immunotherapy
por: Gorczynski, Reginald M., et al.
Publicado: (2014)

Checkpoint blockade in solid tumors and B-cell malignancies, with special consideration of the role of CD200
por: Gorczynski, Reginald M, et al.
Publicado: (2017)

Potent and rapid reversal of the von Willebrand factor inhibitor aptamer BT200
por: Zhu, Shuhao, et al.
Publicado: (2020)

Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2
por: Wu, Florence TH, et al.
Publicado: (2015)

Topical Delivery of Immunosuppression to Prolong Xenogeneic and Allogeneic Split-Thickness Skin Graft Survival
por: Mastroianni, Melissa, et al.
Publicado: (2018)

Prolonged Survival of Subcutaneous Allogeneic Islet Graft by Donor Chimerism without Immunosuppressive Treatment
por: Hsu, Brend Ray-Sea, et al.
Publicado: (2017)

Over-Expression of CD200 Protects Mice from Dextran Sodium Sulfate Induced Colitis
por: Chen, Zhiqi, et al.
Publicado: (2016)

Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF
por: Chen, Zhiqi, et al.
Publicado: (2010)

Induction of Macrophage-Like Immunosuppressive Cells from Mouse ES Cells That Contribute to Prolong Allogeneic Graft Survival
por: Kudo, Hiroya, et al.
Publicado: (2014)

Pharmacological preconditioning with adenosine A(1) receptor agonist induces immunosuppression and improves graft survival in novel allogeneic transplantation models
por: Naamani, Oshri, et al.
Publicado: (2020)

Targeting T-cell malignancies using allogeneic double-negative CD4-CAR-T cells
por: Fang, Karen Kai-Lin, et al.
Publicado: (2023)

Glypican-6 promotes the growth of developing long bones by stimulating Hedgehog signaling
por: Capurro, Mariana, et al.
Publicado: (2017)

CD200 promotes immunosuppression in the pancreatic tumor microenvironment
por: Choueiry, Fouad, et al.
Publicado: (2020)

Inmunología basada en la resolución de problemas
por: Gorczynski, Reginald M.
Publicado: (2007)

Phototoxic aptamers selectively enter and kill epithelial cancer cells
por: Ferreira, Cátia S. M., et al.
Publicado: (2009)

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
por: Moertel, Christopher L, et al.
Publicado: (2014)

Design of Potent and Controllable Anticoagulants Using DNA Aptamers and Nanostructures
por: Rangnekar, Abhijit, et al.
Publicado: (2016)

Allogeneic grafts of spontaneous canine melanomas and their cell culture strains in neonatal immunosuppressed dogs.
por: Betton, G. R., et al.
Publicado: (1976)

Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability
por: Burke, Jacqueline A., et al.
Publicado: (2022)

Toward a New Kind of Vaccine: A Logical Extension of the Symmetrical Immune Network Theory
por: Gorczynski, Reginald, et al.
Publicado: (2017)

The pro-tumor effect of CD200 expression is not mimicked by agonistic CD200R antibodies
por: Pilch, Zofia, et al.
Publicado: (2019)

Immunosuppressants: Prolonged COVID: 3 case reports
Publicado: (2021)

An evolved ribosome-inactivating protein targets and kills human melanoma cells in vitro and in vivo
por: Cheung, Melissa C, et al.
Publicado: (2010)

Mechanism(s) of prolonged attenuation of allergic responses after modulation of idiotypic regulatory network
por: Gorczynski, R. M., et al.
Publicado: (2019)

Dissection of Agonistic and Blocking Effects of CD200 Receptor Antibodies
por: Akkaya, Munir, et al.
Publicado: (2013)

The Competition of Charge Remote and Charge Directed Fragmentation Mechanisms in Quaternary Ammonium Salt Derivatized Peptides—An Isotopic Exchange Study
por: Cydzik, Marzena, et al.
Publicado: (2011)

A Cannabinoid 2-Selective Agonist Inhibits Allogeneic Skin Graft Rejection In Vivo
por: Jayarajan, Senthil, et al.
Publicado: (2022)

Agonistic nanobodies and antibodies to human VISTA
por: Ma, Yu-Heng Vivian, et al.
Publicado: (2021)

The aptamer BT200 blocks von Willebrand factor and platelet function in blood of stroke patients
por: Kovacevic, Katarina D., et al.
Publicado: (2021)

Systemic Immunosuppression for Limbal Allograft and Allogenic Limbal Epithelial Cell Transplantation
por: Serna-Ojeda, Juan Carlos, et al.
Publicado: (2020)

PEGDA microencapsulated allogeneic islets reverse canine diabetes without immunosuppression
por: Harrington, Stephen, et al.
Publicado: (2022)

Oral cancer after prolonged immunosuppression for multiorgan chronic graft-versus-host disease
por: de Araújo, Renata Lins Fuentes, et al.
Publicado: (2014)

A DNA origami-based aptamer nanoarray for potent and reversible anticoagulation in hemodialysis
por: Zhao, Shuai, et al.
Publicado: (2021)

A neutralizable dimeric anti-thrombin aptamer with potent anticoagulant activity in mice
por: Nagano, Masanobu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e3vhf5nm9cve57j9tmm081alqp